The Relationship Between FLT3 Mutations And Complete Remission Of AML Patients Referring To Shariati Hospital
Background and Aim: FLT3 gene is a member of class III receptor Tyrosine Kinase, which is expressed in most patients with acute myeloid leukemia (AML). Mutations of FLT3 such as Internal Tandem Duplication (ITD) and point mutation of the D835 are the most common genetic defects in myeloid leukemia....
Saved in:
Main Authors: | Sakineh Abbasi (Author), Abdollatif Ajdari (Author), Shahin Mohammadi (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2013-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Relationship Between FLT3 Mutations And Complete Remission Of AML Patients Referring To Shariati Hospital
by: Sakineh Abbasi, et al.
Published: (2013) -
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
by: Franziska Schmidt, et al.
Published: (2022) -
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3‐ITD AML
by: Daelynn R. Buelow, et al.
Published: (2019) -
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy
by: Sankaranarayan Kannan, et al.
Published: (2022) -
Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
by: Li Liu, et al.
Published: (2024)